Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy.

作者信息

Hammond Emma, McKinnon Elizabeth, Mallal Simon, Nolan David

机构信息

Centre for Clinical Immunology and Biomedical Statistics, Murdoch University, South Street, Murdoch, Western Australia 6150, Australia.

出版信息

AIDS. 2008 Nov 30;22(18):2540-3. doi: 10.1097/QAD.0b013e328319807f.

DOI:10.1097/QAD.0b013e328319807f

PMID:19005279

Abstract

摘要

相似文献

Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy.

AIDS. 2008 Nov 30;22(18):2540-3. doi: 10.1097/QAD.0b013e328319807f.

Anti-HIV agents. Controversial findings on abacavir and heart attacks.

TreatmentUpdate. 2008 Mar;20(2):1-5.

Heart attack risk with abacavir and didanosine.使用阿巴卡韦和去羟肌苷引发心脏病发作的风险。

AIDS Patient Care STDS. 2008 Apr;22(4):346-7.

FDA notifications. Ongoing safety review of abacavir, possible MI risk.美国食品药品监督管理局通知。对阿巴卡韦进行持续安全性审查，存在心肌梗死风险。

AIDS Alert. 2011 May;26(5):58-9.

FDA notifications. Large study suggests heart attack risk from use of abacavir or didanosine.美国食品药品监督管理局通知。大型研究表明使用阿巴卡韦或去羟肌苷有心脏病发作风险。

AIDS Alert. 2008 May;23(5):58-9.

Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management.HIV感染患者的心肌梗死风险：流行病学、发病机制及临床管理

AIDS. 2010 Mar 27;24(6):789-802. doi: 10.1097/QAD.0b013e328337afdf.

Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.在临床实践中实施危害人数：接受阿巴卡韦治疗的 HIV-1 感染患者的心肌梗死风险。

HIV Med. 2010 Mar;11(3):200-8. doi: 10.1111/j.1468-1293.2009.00763.x. Epub 2009 Oct 27.

Acute respiratory manifestations of the abacavir hypersensitivity reaction.

AIDS. 2006 Jan 9;20(2):301-2. doi: 10.1097/01.aids.0000199833.87606.95.

Parsonage-Turner syndrome: a rare case of abacavir hypersensitivity reaction in HIV-infected patients.帕森奇-特纳综合征：1例HIV感染患者发生阿巴卡韦超敏反应的罕见病例。

J Infect. 2008 Jul;57(1):88-90. doi: 10.1016/j.jinf.2008.05.001. Epub 2008 Jun 2.

Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction.基于阿巴卡韦的治疗不会影响与心血管功能障碍相关的生物学机制。

AIDS. 2010 Jan 28;24(3):F1-9. doi: 10.1097/QAD.0b013e32833562c5.

引用本文的文献

Association of Antiretroviral Therapy with Platelet Function and Systemic Inflammatory Response in People Living with HIV: A Cross-Sectional Study.抗逆转录病毒疗法与HIV感染者血小板功能及全身炎症反应的关联：一项横断面研究。

Microorganisms. 2023 Apr 6;11(4):958. doi: 10.3390/microorganisms11040958.

Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.纵向评估卢旺达 HIV 阳性和 HIV 阴性妇女的炎症标志物。

HIV Med. 2018 Nov;19(10):734-744. doi: 10.1111/hiv.12665. Epub 2018 Aug 30.

Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: A systematic review and meta-analyses of results from 17 epidemiologic studies.与 HIV 感染者接触阿巴卡韦相关的心血管疾病风险：来自 17 项流行病学研究结果的系统评价和荟萃分析。

Int J Antimicrob Agents. 2018 Nov;52(5):541-553. doi: 10.1016/j.ijantimicag.2018.07.010. Epub 2018 Jul 21.

Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study.美国接受抗逆转录病毒治疗的艾滋病毒感染者中，当前、近期及累积接触阿巴卡韦导致心血管事件的风险：一项队列研究。

BMC Infect Dis. 2017 Oct 27;17(1):708. doi: 10.1186/s12879-017-2808-8.

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration.对于感染HIV的个体，使用阿巴卡韦与心肌梗死风险之间是否仍存在关联？一项队列合作研究。

BMC Med. 2016 Mar 31;14:61. doi: 10.1186/s12916-016-0588-4.

Relaxation effect of abacavir on rat basilar arteries.阿巴卡韦对大鼠基底动脉的舒张作用。

PLoS One. 2015 Apr 8;10(4):e0123043. doi: 10.1371/journal.pone.0123043. eCollection 2015.

Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women.阿巴卡韦改变了病毒学抑制的 HIV 感染女性的炎症细胞因子的转录。

J Int AIDS Soc. 2012 Jul 10;15(2):17393. doi: 10.7448/IAS.15.2.17393.

The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients.替诺福韦疗法对 HIV 感染患者动脉粥样硬化进展的有害影响。

Mediators Inflamm. 2012;2012:372305. doi: 10.1155/2012/372305. Epub 2012 May 7.

Short communication: initiation of an abacavir-containing regimen in HIV-infected adults is associated with a smaller decrease in inflammation and endothelial activation markers compared to non-abacavir-containing regimens.简短通讯：与不含阿巴卡韦的治疗方案相比，在HIV感染的成年人中启动含阿巴卡韦的治疗方案与炎症和内皮激活标志物的下降幅度较小有关。

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1561-4. doi: 10.1089/AID.2012.0034. Epub 2012 Apr 26.

Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy.接受抗逆转录病毒治疗的HIV感染者血管和内皮功能尿生物标志物的性别差异。

Antivir Ther. 2012;17(3):485-93. doi: 10.3851/IMP1990. Epub 2011 Dec 14.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验